REVS Performance — Columbia Research Enhanced Value ETF
Data updated: 2026-09-28
REVS returned +17.45% year to date and +27.32% over one year to Jul 2026. Annualised returns are +17.70% over 3 years and +12.48% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $163, against $156 for the category, and to $127 over one year, against $122. Volatility over the past three years was 12.49% a year. In the 12 months to Jul 2026 the fund took in a net $206.4M, and assets reached $333.74M.
REVS Growth of $100
What $100 invested in Columbia Research Enhanced Value ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | REVS | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $127 | $122 |
| 3 years (Aug 2023 – Jul 2026) | $163 | $156 |
| 5 years (Aug 2021 – Jul 2026) | $180 | $168 |
| Since data start (Sep 2019 – Jul 2026) | $239 | $231 |
REVS Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.45% |
| 1 year | +27.32% |
| 3 years (annualised) | +17.70% |
| 5 years (annualised) | +12.48% |
REVS Annual Returns
Calendar-year total returns of Columbia Research Enhanced Value ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +17.45% |
| 2025 | +16.59% |
| 2024 | +16.39% |
| 2023 | +13.19% |
| 2022 | −5.81% |
| 2021 | +28.34% |
| 2020 | +1.48% |
| 2019 (Sep–Dec) | +7.86% |
REVS Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.6% | +2.1% | −4.3% | +7.7% | +2.3% | −0.1% | +5.4% | — | — | — | — | — |
| 2025 | +4.5% | +0.2% | −3.1% | −3.3% | +4.2% | +3.8% | +1.3% | +4.1% | +0.8% | +0.2% | +2.3% | +0.8% |
| 2024 | +1.2% | +3.4% | +5.7% | −4.6% | +2.6% | −0.6% | +5.2% | +2.6% | +1.0% | 0.0% | +6.1% | −6.5% |
| 2023 | +5.5% | −2.9% | −0.9% | +2.0% | −3.4% | +6.7% | +3.7% | −3.1% | −3.0% | −3.7% | +7.0% | +5.6% |
| 2022 | −1.4% | −1.1% | +2.6% | −4.5% | +1.9% | −8.4% | +5.4% | −2.5% | −8.5% | +10.4% | +6.1% | −4.0% |
| 2021 | −0.3% | +5.2% | +7.4% | +4.1% | +3.0% | −0.9% | +1.2% | +2.8% | −4.1% | +4.3% | −3.4% | +6.7% |
| 2020 | −2.2% | −9.9% | −16.3% | +11.9% | +3.4% | −0.7% | +3.4% | +4.0% | −3.2% | −1.4% | +13.0% | +3.4% |
| 2019 | — | — | — | — | — | — | — | — | +0.2% | +1.8% | +2.7% | +2.9% |
REVS Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.49%
- 3-year Sharpe ratio: 1.06 (vs 4.5% risk-free rate)
- Best month: +7.73% (Apr 2026)
- Worst month: −6.49% (Dec 2024)
REVS Fund Flows
Monthly money in and out of Columbia Research Enhanced Value ETF, from SEC Form N-PORT.
- 12-month net flow: $206.4M
- 12-month gross sales (incl. reinvestments): $335.3M
- Sales ÷ redemptions: 2.60×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $13.2M | $6.6M | $6.6M |
| Jun 2026 | $90.0M | $83.9M | $6.1M |
| May 2026 | $13.9M | $0 | $13.9M |
| Apr 2026 | $18.4M | $0 | $18.4M |
| Mar 2026 | $39.3M | $5.6M | $33.7M |
| Feb 2026 | $20.0M | $0 | $20.0M |
| Jan 2026 | $53.6M | $0 | $53.6M |
| Dec 2025 | $68.3M | $27.6M | $40.7M |
| Nov 2025 | $7.0M | $0 | $7.0M |
| Oct 2025 | $7.0M | $0 | $7.0M |
| Sep 2025 | $691K | $0 | $691K |
| Aug 2025 | $4.1M | $5.3M | −$1.2M |
REVS Assets Under Management
Net assets of Columbia Research Enhanced Value ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $333.74M |
| 2026-04-30 | $283.68M |
| 2026-01-31 | $196.82M |
| 2025-10-31 | $90.19M |
| 2025-07-31 | $79.83M |
| 2025-04-30 | $68.62M |
| 2025-01-31 | $65.94M |
| 2024-10-31 | $66.05M |
| 2024-07-31 | $55.16M |
| 2024-04-30 | $49.71M |
| 2024-01-31 | $23.57M |
| 2023-10-31 | $18.67M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.